Does MONTELUKAST Cause Subcutaneous emphysema? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Subcutaneous emphysema have been filed in association with MONTELUKAST (Montelukast). This represents 0.0% of all adverse event reports for MONTELUKAST.
7
Reports of Subcutaneous emphysema with MONTELUKAST
0.0%
of all MONTELUKAST reports
0
Deaths
4
Hospitalizations
How Dangerous Is Subcutaneous emphysema From MONTELUKAST?
Of the 7 reports, 4 (57.1%) required hospitalization.
Is Subcutaneous emphysema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MONTELUKAST. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does MONTELUKAST Cause?
Asthma (8,372)
Dyspnoea (6,354)
Wheezing (5,159)
Drug ineffective (3,539)
Cough (3,475)
Therapeutic product effect incomplete (3,352)
Anxiety (2,994)
Loss of personal independence in daily activities (2,736)
Sleep disorder due to a general medical condition (2,101)
Obstructive airways disorder (2,073)
What Other Drugs Cause Subcutaneous emphysema?
PREDNISOLONE (76)
PREDNISONE (53)
METHYLPREDNISOLONE (51)
TACROLIMUS (44)
RITUXIMAB (34)
DEXAMETHASONE (30)
MYCOPHENOLATE MOFETIL (30)
METHOTREXATE (23)
CARBON DIOXIDE (20)
REMDESIVIR (20)
Which MONTELUKAST Alternatives Have Lower Subcutaneous emphysema Risk?
MONTELUKAST vs MONTELUKAST\MONTELUKAST
MONTELUKAST vs MONTMORILLONITE
MONTELUKAST vs MORNIFLUMATE
MONTELUKAST vs MOROCTOCOG ALFA
MONTELUKAST vs MORPHINE